アンジオポエチン2のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Angiopoietin 2 Market Insights and Forecast to 2028

• レポートコード：QY2203B01553 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のアンジオポエチン2の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアンジオポエチン2の世界市場のxxx％を占める「Atu-111」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のアンジオポエチン2の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのアンジオポエチン2市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのアンジオポエチン2市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 アンジオポエチン2のグローバル主要メーカーには、Amgen Inc.、AnGes MG, Inc.、Boehringer Ingelheim GmbH、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、MedImmune, LLC、Regeneron Pharmaceuticals, Inc.、RXi Pharmaceuticals Corporation、Silence Therapeutics Plc、Synergys Biotherapeutics, Inc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 アンジオポエチン2市場は、種類と用途によって区分されます。世界のアンジオポエチン2市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 Atu-111、BI-836880、LY-3127804、MEDI-3617、その他 【用途別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - アンジオポエチン2製品概要 - 種類別市場（Atu-111、BI-836880、LY-3127804、MEDI-3617、その他） - 用途別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のアンジオポエチン2販売量予測2017-2028 - 世界のアンジオポエチン2売上予測2017-2028 - アンジオポエチン2の地域別販売量 - アンジオポエチン2の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別アンジオポエチン2販売量 - 主要メーカー別アンジオポエチン2売上 - 主要メーカー別アンジオポエチン2価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（Atu-111、BI-836880、LY-3127804、MEDI-3617、その他） - アンジオポエチン2の種類別販売量 - アンジオポエチン2の種類別売上 - アンジオポエチン2の種類別価格 ・用途別市場規模（病院、診療所、その他） - アンジオポエチン2の用途別販売量 - アンジオポエチン2の用途別売上 - アンジオポエチン2の用途別価格 ・北米市場 - 北米のアンジオポエチン2市場規模（種類別、用途別） - 主要国別のアンジオポエチン2市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのアンジオポエチン2市場規模（種類別、用途別） - 主要国別のアンジオポエチン2市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のアンジオポエチン2市場規模（種類別、用途別） - 主要国別のアンジオポエチン2市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のアンジオポエチン2市場規模（種類別、用途別） - 主要国別のアンジオポエチン2市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのアンジオポエチン2市場規模（種類別、用途別） - 主要国別のアンジオポエチン2市場規模（トルコ、サウジアラビア） ・企業情報 Amgen Inc.、AnGes MG, Inc.、Boehringer Ingelheim GmbH、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、MedImmune, LLC、Regeneron Pharmaceuticals, Inc.、RXi Pharmaceuticals Corporation、Silence Therapeutics Plc、Synergys Biotherapeutics, Inc. ・産業チェーン及び販売チャネル分析 - アンジオポエチン2の産業チェーン分析 - アンジオポエチン2の原材料 - アンジオポエチン2の生産プロセス - アンジオポエチン2の販売及びマーケティング - アンジオポエチン2の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - アンジオポエチン2の産業動向 - アンジオポエチン2のマーケットドライバー - アンジオポエチン2の課題 - アンジオポエチン2の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Angiopoietin 2 Market
Due to the COVID-19 pandemic, the global Angiopoietin 2 market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Atu-111 accounting for % of the Angiopoietin 2 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Angiopoietin 2 market size is valued at US$ million in 2021, while the US and Europe Angiopoietin 2 are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Angiopoietin 2 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Angiopoietin 2 include Amgen Inc., AnGes MG, Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., MedImmune, LLC, Regeneron Pharmaceuticals, Inc., RXi Pharmaceuticals Corporation and Silence Therapeutics Plc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Angiopoietin 2 Scope and Segment
Angiopoietin 2 market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Angiopoietin 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Segment by Application
Hospital
Clinic
Others
By Company
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Angiopoietin 2 Product Introduction
1.2 Market by Type
1.2.1 Global Angiopoietin 2 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Atu-111
1.2.3 BI-836880
1.2.4 LY-3127804
1.2.5 MEDI-3617
1.2.6 Others
1.3 Market by Application
1.3.1 Global Angiopoietin 2 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Angiopoietin 2 Sales Estimates and Forecasts 2017-2028
2.2 Global Angiopoietin 2 Revenue Estimates and Forecasts 2017-2028
2.3 Global Angiopoietin 2 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Angiopoietin 2 Sales by Region
2.4.1 Global Angiopoietin 2 Sales by Region (2017-2022)
2.4.2 Global Sales Angiopoietin 2 by Region (2023-2028)
2.5 Global Angiopoietin 2 Revenue by Region
2.5.1 Global Angiopoietin 2 Revenue by Region (2017-2022)
2.5.2 Global Angiopoietin 2 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Angiopoietin 2 Sales by Manufacturers
3.1.1 Global Top Angiopoietin 2 Manufacturers by Sales (2017-2022)
3.1.2 Global Angiopoietin 2 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Angiopoietin 2 in 2021
3.2 Global Angiopoietin 2 Revenue by Manufacturers
3.2.1 Global Angiopoietin 2 Revenue by Manufacturers (2017-2022)
3.2.2 Global Angiopoietin 2 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Angiopoietin 2 Revenue in 2021
3.3 Global Angiopoietin 2 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Angiopoietin 2 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Angiopoietin 2 Sales by Type
4.1.1 Global Angiopoietin 2 Historical Sales by Type (2017-2022)
4.1.2 Global Angiopoietin 2 Forecasted Sales by Type (2023-2028)
4.1.3 Global Angiopoietin 2 Sales Market Share by Type (2017-2028)
4.2 Global Angiopoietin 2 Revenue by Type
4.2.1 Global Angiopoietin 2 Historical Revenue by Type (2017-2022)
4.2.2 Global Angiopoietin 2 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Angiopoietin 2 Revenue Market Share by Type (2017-2028)
4.3 Global Angiopoietin 2 Price by Type
4.3.1 Global Angiopoietin 2 Price by Type (2017-2022)
4.3.2 Global Angiopoietin 2 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Angiopoietin 2 Sales by Application
5.1.1 Global Angiopoietin 2 Historical Sales by Application (2017-2022)
5.1.2 Global Angiopoietin 2 Forecasted Sales by Application (2023-2028)
5.1.3 Global Angiopoietin 2 Sales Market Share by Application (2017-2028)
5.2 Global Angiopoietin 2 Revenue by Application
5.2.1 Global Angiopoietin 2 Historical Revenue by Application (2017-2022)
5.2.2 Global Angiopoietin 2 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Angiopoietin 2 Revenue Market Share by Application (2017-2028)
5.3 Global Angiopoietin 2 Price by Application
5.3.1 Global Angiopoietin 2 Price by Application (2017-2022)
5.3.2 Global Angiopoietin 2 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Angiopoietin 2 Market Size by Type
6.1.1 North America Angiopoietin 2 Sales by Type (2017-2028)
6.1.2 North America Angiopoietin 2 Revenue by Type (2017-2028)
6.2 North America Angiopoietin 2 Market Size by Application
6.2.1 North America Angiopoietin 2 Sales by Application (2017-2028)
6.2.2 North America Angiopoietin 2 Revenue by Application (2017-2028)
6.3 North America Angiopoietin 2 Market Size by Country
6.3.1 North America Angiopoietin 2 Sales by Country (2017-2028)
6.3.2 North America Angiopoietin 2 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Angiopoietin 2 Market Size by Type
7.1.1 Europe Angiopoietin 2 Sales by Type (2017-2028)
7.1.2 Europe Angiopoietin 2 Revenue by Type (2017-2028)
7.2 Europe Angiopoietin 2 Market Size by Application
7.2.1 Europe Angiopoietin 2 Sales by Application (2017-2028)
7.2.2 Europe Angiopoietin 2 Revenue by Application (2017-2028)
7.3 Europe Angiopoietin 2 Market Size by Country
7.3.1 Europe Angiopoietin 2 Sales by Country (2017-2028)
7.3.2 Europe Angiopoietin 2 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Angiopoietin 2 Market Size by Type
8.1.1 Asia Pacific Angiopoietin 2 Sales by Type (2017-2028)
8.1.2 Asia Pacific Angiopoietin 2 Revenue by Type (2017-2028)
8.2 Asia Pacific Angiopoietin 2 Market Size by Application
8.2.1 Asia Pacific Angiopoietin 2 Sales by Application (2017-2028)
8.2.2 Asia Pacific Angiopoietin 2 Revenue by Application (2017-2028)
8.3 Asia Pacific Angiopoietin 2 Market Size by Region
8.3.1 Asia Pacific Angiopoietin 2 Sales by Region (2017-2028)
8.3.2 Asia Pacific Angiopoietin 2 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Angiopoietin 2 Market Size by Type
9.1.1 Latin America Angiopoietin 2 Sales by Type (2017-2028)
9.1.2 Latin America Angiopoietin 2 Revenue by Type (2017-2028)
9.2 Latin America Angiopoietin 2 Market Size by Application
9.2.1 Latin America Angiopoietin 2 Sales by Application (2017-2028)
9.2.2 Latin America Angiopoietin 2 Revenue by Application (2017-2028)
9.3 Latin America Angiopoietin 2 Market Size by Country
9.3.1 Latin America Angiopoietin 2 Sales by Country (2017-2028)
9.3.2 Latin America Angiopoietin 2 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Angiopoietin 2 Market Size by Type
10.1.1 Middle East and Africa Angiopoietin 2 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Angiopoietin 2 Revenue by Type (2017-2028)
10.2 Middle East and Africa Angiopoietin 2 Market Size by Application
10.2.1 Middle East and Africa Angiopoietin 2 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Angiopoietin 2 Revenue by Application (2017-2028)
10.3 Middle East and Africa Angiopoietin 2 Market Size by Country
10.3.1 Middle East and Africa Angiopoietin 2 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Angiopoietin 2 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Corporation Information
11.1.2 Amgen Inc. Overview
11.1.3 Amgen Inc. Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amgen Inc. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Inc. Recent Developments
11.2 AnGes MG, Inc.
11.2.1 AnGes MG, Inc. Corporation Information
11.2.2 AnGes MG, Inc. Overview
11.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AnGes MG, Inc. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AnGes MG, Inc. Recent Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Corporation Information
11.3.2 Boehringer Ingelheim GmbH Overview
11.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim GmbH Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company Recent Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd. Overview
11.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.6 MedImmune, LLC
11.6.1 MedImmune, LLC Corporation Information
11.6.2 MedImmune, LLC Overview
11.6.3 MedImmune, LLC Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 MedImmune, LLC Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 MedImmune, LLC Recent Developments
11.7 Regeneron Pharmaceuticals, Inc.
11.7.1 Regeneron Pharmaceuticals, Inc. Corporation Information
11.7.2 Regeneron Pharmaceuticals, Inc. Overview
11.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Regeneron Pharmaceuticals, Inc. Recent Developments
11.8 RXi Pharmaceuticals Corporation
11.8.1 RXi Pharmaceuticals Corporation Corporation Information
11.8.2 RXi Pharmaceuticals Corporation Overview
11.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 RXi Pharmaceuticals Corporation Recent Developments
11.9 Silence Therapeutics Plc
11.9.1 Silence Therapeutics Plc Corporation Information
11.9.2 Silence Therapeutics Plc Overview
11.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Silence Therapeutics Plc Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Silence Therapeutics Plc Recent Developments
11.10 Synergys Biotherapeutics, Inc.
11.10.1 Synergys Biotherapeutics, Inc. Corporation Information
11.10.2 Synergys Biotherapeutics, Inc. Overview
11.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Synergys Biotherapeutics, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Angiopoietin 2 Industry Chain Analysis
12.2 Angiopoietin 2 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Angiopoietin 2 Production Mode & Process
12.4 Angiopoietin 2 Sales and Marketing
12.4.1 Angiopoietin 2 Sales Channels
12.4.2 Angiopoietin 2 Distributors
12.5 Angiopoietin 2 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Angiopoietin 2 Industry Trends
13.2 Angiopoietin 2 Market Drivers
13.3 Angiopoietin 2 Market Challenges
13.4 Angiopoietin 2 Market Restraints
14 Key Findings in The Global Angiopoietin 2 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Angiopoietin 2 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Atu-111
Table 3. Major Manufacturers of BI-836880
Table 4. Major Manufacturers of LY-3127804
Table 5. Major Manufacturers of MEDI-3617
Table 6. Major Manufacturers of Others
Table 7. Global Angiopoietin 2 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Angiopoietin 2 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Angiopoietin 2 Sales by Region (2017-2022) & (K Pcs)
Table 10. Global Angiopoietin 2 Sales Market Share by Region (2017-2022)
Table 11. Global Angiopoietin 2 Sales by Region (2023-2028) & (K Pcs)
Table 12. Global Angiopoietin 2 Sales Market Share by Region (2023-2028)
Table 13. Global Angiopoietin 2 Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Angiopoietin 2 Revenue Market Share by Region (2017-2022)
Table 15. Global Angiopoietin 2 Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Angiopoietin 2 Revenue Market Share by Region (2023-2028)
Table 17. Global Angiopoietin 2 Sales by Manufacturers (2017-2022) & (K Pcs)
Table 18. Global Angiopoietin 2 Sales Share by Manufacturers (2017-2022)
Table 19. Global Angiopoietin 2 Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Angiopoietin 2 Revenue Share by Manufacturers (2017-2022)
Table 21. Angiopoietin 2 Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 22. Global Angiopoietin 2 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Angiopoietin 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiopoietin 2 as of 2021)
Table 24. Angiopoietin 2 Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Angiopoietin 2 Product Offered
Table 26. Date of Manufacturers Enter into Angiopoietin 2 Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 29. Global Angiopoietin 2 Sales by Type (2023-2028) & (K Pcs)
Table 30. Global Angiopoietin 2 Sales Share by Type (2017-2022)
Table 31. Global Angiopoietin 2 Sales Share by Type (2023-2028)
Table 32. Global Angiopoietin 2 Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Angiopoietin 2 Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Angiopoietin 2 Revenue Share by Type (2017-2022)
Table 35. Global Angiopoietin 2 Revenue Share by Type (2023-2028)
Table 36. Angiopoietin 2 Price by Type (2017-2022) & (USD/Pcs)
Table 37. Global Angiopoietin 2 Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 38. Global Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 39. Global Angiopoietin 2 Sales by Application (2023-2028) & (K Pcs)
Table 40. Global Angiopoietin 2 Sales Share by Application (2017-2022)
Table 41. Global Angiopoietin 2 Sales Share by Application (2023-2028)
Table 42. Global Angiopoietin 2 Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Angiopoietin 2 Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Angiopoietin 2 Revenue Share by Application (2017-2022)
Table 45. Global Angiopoietin 2 Revenue Share by Application (2023-2028)
Table 46. Angiopoietin 2 Price by Application (2017-2022) & (USD/Pcs)
Table 47. Global Angiopoietin 2 Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 48. North America Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 49. North America Angiopoietin 2 Sales by Type (2023-2028) & (K Pcs)
Table 50. North America Angiopoietin 2 Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Angiopoietin 2 Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 53. North America Angiopoietin 2 Sales by Application (2023-2028) & (K Pcs)
Table 54. North America Angiopoietin 2 Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Angiopoietin 2 Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Angiopoietin 2 Sales by Country (2017-2022) & (K Pcs)
Table 57. North America Angiopoietin 2 Sales by Country (2023-2028) & (K Pcs)
Table 58. North America Angiopoietin 2 Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Angiopoietin 2 Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 61. Europe Angiopoietin 2 Sales by Type (2023-2028) & (K Pcs)
Table 62. Europe Angiopoietin 2 Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Angiopoietin 2 Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 65. Europe Angiopoietin 2 Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Angiopoietin 2 Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Angiopoietin 2 Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Angiopoietin 2 Sales by Country (2017-2022) & (K Pcs)
Table 69. Europe Angiopoietin 2 Sales by Country (2023-2028) & (K Pcs)
Table 70. Europe Angiopoietin 2 Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Angiopoietin 2 Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 73. Asia Pacific Angiopoietin 2 Sales by Type (2023-2028) & (K Pcs)
Table 74. Asia Pacific Angiopoietin 2 Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Angiopoietin 2 Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia Pacific Angiopoietin 2 Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia Pacific Angiopoietin 2 Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Angiopoietin 2 Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Angiopoietin 2 Sales by Region (2017-2022) & (K Pcs)
Table 81. Asia Pacific Angiopoietin 2 Sales by Region (2023-2028) & (K Pcs)
Table 82. Asia Pacific Angiopoietin 2 Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Angiopoietin 2 Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 85. Latin America Angiopoietin 2 Sales by Type (2023-2028) & (K Pcs)
Table 86. Latin America Angiopoietin 2 Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Angiopoietin 2 Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 89. Latin America Angiopoietin 2 Sales by Application (2023-2028) & (K Pcs)
Table 90. Latin America Angiopoietin 2 Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Angiopoietin 2 Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Angiopoietin 2 Sales by Country (2017-2022) & (K Pcs)
Table 93. Latin America Angiopoietin 2 Sales by Country (2023-2028) & (K Pcs)
Table 94. Latin America Angiopoietin 2 Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Angiopoietin 2 Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Angiopoietin 2 Sales by Type (2017-2022) & (K Pcs)
Table 97. Middle East and Africa Angiopoietin 2 Sales by Type (2023-2028) & (K Pcs)
Table 98. Middle East and Africa Angiopoietin 2 Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Angiopoietin 2 Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Angiopoietin 2 Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East and Africa Angiopoietin 2 Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East and Africa Angiopoietin 2 Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Angiopoietin 2 Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Angiopoietin 2 Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa Angiopoietin 2 Sales by Country (2023-2028) & (K Pcs)
Table 106. Middle East and Africa Angiopoietin 2 Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Angiopoietin 2 Revenue by Country (2023-2028) & (US$ Million)
Table 108. Amgen Inc. Corporation Information
Table 109. Amgen Inc. Description and Major Businesses
Table 110. Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 111. Amgen Inc. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Amgen Inc. Recent Developments
Table 113. AnGes MG, Inc. Corporation Information
Table 114. AnGes MG, Inc. Description and Major Businesses
Table 115. AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 116. AnGes MG, Inc. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AnGes MG, Inc. Recent Developments
Table 118. Boehringer Ingelheim GmbH Corporation Information
Table 119. Boehringer Ingelheim GmbH Description and Major Businesses
Table 120. Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 121. Boehringer Ingelheim GmbH Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Boehringer Ingelheim GmbH Recent Developments
Table 123. Eli Lilly and Company Corporation Information
Table 124. Eli Lilly and Company Description and Major Businesses
Table 125. Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 126. Eli Lilly and Company Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Eli Lilly and Company Recent Developments
Table 128. F. Hoffmann-La Roche Ltd. Corporation Information
Table 129. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 130. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 131. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. F. Hoffmann-La Roche Ltd. Recent Developments
Table 133. MedImmune, LLC Corporation Information
Table 134. MedImmune, LLC Description and Major Businesses
Table 135. MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 136. MedImmune, LLC Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. MedImmune, LLC Recent Developments
Table 138. Regeneron Pharmaceuticals, Inc. Corporation Information
Table 139. Regeneron Pharmaceuticals, Inc. Description and Major Businesses
Table 140. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 141. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Regeneron Pharmaceuticals, Inc. Recent Developments
Table 143. RXi Pharmaceuticals Corporation Corporation Information
Table 144. RXi Pharmaceuticals Corporation Description and Major Businesses
Table 145. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 146. RXi Pharmaceuticals Corporation Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. RXi Pharmaceuticals Corporation Recent Developments
Table 148. Silence Therapeutics Plc Corporation Information
Table 149. Silence Therapeutics Plc Description and Major Businesses
Table 150. Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 151. Silence Therapeutics Plc Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Silence Therapeutics Plc Recent Developments
Table 153. Synergys Biotherapeutics, Inc. Corporation Information
Table 154. Synergys Biotherapeutics, Inc. Description and Major Businesses
Table 155. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 156. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Synergys Biotherapeutics, Inc. Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Angiopoietin 2 Distributors List
Table 161. Angiopoietin 2 Customers List
Table 162. Angiopoietin 2 Market Trends
Table 163. Angiopoietin 2 Market Drivers
Table 164. Angiopoietin 2 Market Challenges
Table 165. Angiopoietin 2 Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiopoietin 2 Product Picture
Figure 3. Global Angiopoietin 2 Market Share by Type in 2021 & 2028
Figure 3. Atu-111 Product Picture
Figure 4. BI-836880 Product Picture
Figure 5. LY-3127804 Product Picture
Figure 6. MEDI-3617 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Angiopoietin 2 Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Angiopoietin 2 Report Years Considered
Figure 13. Global Angiopoietin 2 Sales 2017-2028 (K Pcs)
Figure 14. Global Angiopoietin 2 Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Angiopoietin 2 Revenue 2017-2028 (US$ Million)
Figure 16. Global Angiopoietin 2 Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Angiopoietin 2 Sales Market Share by Region (2017-2022)
Figure 18. Global Angiopoietin 2 Sales Market Share by Region (2023-2028)
Figure 19. North America Angiopoietin 2 Sales YoY (2017-2028) & (K Pcs)
Figure 20. North America Angiopoietin 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Angiopoietin 2 Sales YoY (2017-2028) & (K Pcs)
Figure 22. Europe Angiopoietin 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Angiopoietin 2 Sales YoY (2017-2028) & (K Pcs)
Figure 24. Asia-Pacific Angiopoietin 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Angiopoietin 2 Sales YoY (2017-2028) & (K Pcs)
Figure 26. Latin America Angiopoietin 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Angiopoietin 2 Sales YoY (2017-2028) & (K Pcs)
Figure 28. Middle East & Africa Angiopoietin 2 Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Angiopoietin 2 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Angiopoietin 2 in the World: Market Share by Angiopoietin 2 Revenue in 2021
Figure 31. Global Angiopoietin 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Angiopoietin 2 Sales Market Share by Type (2017-2028)
Figure 33. Global Angiopoietin 2 Revenue Market Share by Type (2017-2028)
Figure 34. Global Angiopoietin 2 Sales Market Share by Application (2017-2028)
Figure 35. Global Angiopoietin 2 Revenue Market Share by Application (2017-2028)
Figure 36. North America Angiopoietin 2 Sales Market Share by Type (2017-2028)
Figure 37. North America Angiopoietin 2 Revenue Market Share by Type (2017-2028)
Figure 38. North America Angiopoietin 2 Sales Market Share by Application (2017-2028)
Figure 39. North America Angiopoietin 2 Revenue Market Share by Application (2017-2028)
Figure 40. North America Angiopoietin 2 Sales Share by Country (2017-2028)
Figure 41. North America Angiopoietin 2 Revenue Share by Country (2017-2028)
Figure 42. U.S. Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Angiopoietin 2 Sales Market Share by Type (2017-2028)
Figure 45. Europe Angiopoietin 2 Revenue Market Share by Type (2017-2028)
Figure 46. Europe Angiopoietin 2 Sales Market Share by Application (2017-2028)
Figure 47. Europe Angiopoietin 2 Revenue Market Share by Application (2017-2028)
Figure 48. Europe Angiopoietin 2 Sales Share by Country (2017-2028)
Figure 49. Europe Angiopoietin 2 Revenue Share by Country (2017-2028)
Figure 50. Germany Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 51. France Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Angiopoietin 2 Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Angiopoietin 2 Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Angiopoietin 2 Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Angiopoietin 2 Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Angiopoietin 2 Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Angiopoietin 2 Revenue Share by Region (2017-2028)
Figure 61. China Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 64. India Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Angiopoietin 2 Sales Market Share by Type (2017-2028)
Figure 72. Latin America Angiopoietin 2 Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Angiopoietin 2 Sales Market Share by Application (2017-2028)
Figure 74. Latin America Angiopoietin 2 Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Angiopoietin 2 Sales Share by Country (2017-2028)
Figure 76. Latin America Angiopoietin 2 Revenue Share by Country (2017-2028)
Figure 77. Mexico Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Angiopoietin 2 Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Angiopoietin 2 Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Angiopoietin 2 Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Angiopoietin 2 Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Angiopoietin 2 Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Angiopoietin 2 Revenue Share by Country (2017-2028)
Figure 86. Turkey Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 88. U.A.E Angiopoietin 2 Revenue (2017-2028) & (US$ Million)
Figure 89. Angiopoietin 2 Value Chain
Figure 90. Angiopoietin 2 Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

---